ストックスクリーナーアプリを入手
7.99
1.91%
0.15
プレマーケット:
8.00
0.010
+0.13%
前日終値:
$7.84
開ける：
$7.83
24時間の取引高:
2.07M
Relative Volume:
0.54
時価総額：
$570.16M
収益：
-
当期純損益:
$-192.96M
株価収益率:
-2.4212
EPS:
-3.3
ネットキャッシュフロー:
$-167.04M
1週間 パフォーマンス:
-20.02%
1か月 パフォーマンス:
-1.24%
6か月 パフォーマンス:
+301.51%
1年 パフォーマンス:
+207.31%
1日の値動き範囲:
$7.60
$8.055
1週間の範囲:
$7.60
$10.15
52週間の値動き範囲:
$0.783
$10.55
Ventyx Biosciences Inc Stock (VTYX) Company Profile
名前
Ventyx Biosciences Inc
セクター
電話
(760) 407-6511
住所
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
VTYX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
7.99 | 559.45M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-05 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-03-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-11-07 | ダウングレード | Stifel | Buy → Hold |
| 2023-11-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-03-21 | 開始されました | Wells Fargo | Overweight |
| 2022-12-19 | 開始されました | Goldman | Buy |
| 2022-11-17 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-07 | 開始されました | Stifel | Buy |
| 2022-09-01 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-09 | 開始されました | Credit Suisse | Outperform |
| 2022-03-31 | 開始されました | Canaccord Genuity | Buy |
| 2022-02-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-15 | 開始されました | Jefferies | Buy |
| 2021-11-15 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Ventyx Biosciences Inc (VTYX) 最新ニュース
Ventyx Biosciences (NASDAQ:VTYX) Shares Gap DownShould You Sell? - MarketBeat
Ventyx Biosciences, Inc. $VTYX Shares Sold by Sio Capital Management LLC - MarketBeat
Ventyx Biosciences Announces Appointment to Advisory Board - marketscreener.com
Ventyx provides clinical and corporate updates - marketscreener.com
Ventyx Provides Clinical And Corporate Updates - TradingView
Ventyx Biosciences Expands Phase 2 Recurrent Pericarditis Study Into Canada, EU, UK - MarketScreener
Ventyx stock falls after delaying trial data to Q1 2026 By Investing.com - Investing.com Canada
Ventyx strengthens advisory board, expands phase 2 pericarditis study - Investing.com
Ventyx strengthens advisory board, expands phase 2 pericarditis study By Investing.com - Investing.com South Africa
Ventyx Provides Clinical and Corporate Updates - The Manila Times
Ventyx adds advisors and delays trial data to Q1 2026 - StreetInsider
Institutional owners may ignore Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) recent US$77m market cap decline as longer-term profits stay in the green - simplywall.st
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Ventyx Biosciences, Inc. (VTYX) latest stock news and headlines - Yahoo Finance UK
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Reviewing Tharimmune (NASDAQ:THAR) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
Ventyx Biosciences (NASDAQ:VTYX) Reaches New 1-Year HighTime to Buy? - MarketBeat
With 57% ownership, Ventyx Biosciences, Inc. (NASDAQ:VTYX) boasts of strong institutional backing - Yahoo Finance
Ventyx Biosciences (VTYX) Outlook Strengthened by Cost Optimization and Positive Clinical Data - MSN
VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know - MSN
Will Ventyx Biosciences Inc. stock see insider buyingTrade Exit Summary & Weekly High Potential Stock Alerts - newser.com
Does Ventyx Biosciences Inc. stock trade at a discount to peersMarket Volume Report & Weekly High Return Forecasts - newser.com
Is Ventyx Biosciences Inc. stock attractive for growth ETFsJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
How Ventyx Biosciences Inc. stock reacts to bond yieldsJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Ventyx Biosciences (VTYX) Price Target Increased by 12.94% to 13.99 - MSN
Market reaction to Ventyx Biosciences Inc.’s recent newsGold Moves & Safe Capital Investment Plans - newser.com
Can Ventyx Biosciences Inc. stock double in next 5 years2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
[Form 4] Ventyx Biosciences, Inc. Insider Trading Activity - Stock Titan
Is Ventyx Biosciences Inc. still worth holding after the dipStop Loss & Weekly High Potential Stock Alerts - newser.com
Will Ventyx Biosciences Inc. stock recover faster than peersEarnings Growth Report & Pattern Based Trade Signal System - newser.com
How Ventyx Biosciences Inc. stock performs during Fed tightening cycles2025 Pullback Review & AI Driven Stock Reports - newser.com
Ventyx Biosciences at Jefferies Conference: Strategic Focus on NLRP3 Inhibitors - Investing.com Canada
What high frequency data says about Ventyx Biosciences Inc.Quarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
Why Ventyx Biosciences Inc. is moving todayJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com
Ventyx Biosciences Inc (VTYX) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):